Basic information
Biomarker: CEA
Histology type: endometrial carcinoma
Cohort characteristics
Country: Turkey
Region: Malatya
Study type: prospective cross-sectional study
Followed up time :
Subgroup 1 name : study
Subgroup 1 number: 38
Subgroup 2 name: control
Subgroup 2 number: 21
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 59 | early-stage endometrial cancer | 38 | benign endometrial pathologies | 21 |
Sample information
Conclusion: Serum CEA were significantly higher in women with endometrial cancer than in those without cancer. These results may help identify new markers for diagnosing endometrial cancer.
Sample type : serum
Sample method: immunoassay analysis
Expression pattern : high level
Expression elevation: cutoff= 1.26 ng/mL
Disease information
Statictics: Mean ;Range
Subgroup 1 age: 58.5;38–81
Subgroup 2 age: 46;38–73
Related information
UniProt Link: https://www.uniprot.org/uniprotkb?query=Carcinoembryonic%20antigen
Molecular function from UniProt:
HPA link: https://www.proteinatlas.org/search/Carcinoembryonic+antigen
HGNC link: https://www.genenames.org/data/genegroup/#!/group/1317
